期刊文献+

辛伐他汀对血液透析患者血脂水平影响的初步研究 被引量:1

The influence of simvastatin on serum lipid level in patients of hemodialysis:A preliminary study.
原文传递
导出
摘要 目的观察维持性血液透析(MHD)患者血清血脂水平及其特点,前瞻性观察辛伐他汀对MHD患者血清总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL-C)和高密度脂蛋白胆固醇(HDL-C)浓度的影响。方法测定29例MHD患者血清血脂水平,使用辛伐他汀20mg,每日1次,共8周对其中存在血脂异常的13例患者进行干预治疗,其余16例作为对照组;测定两组研究前后血脂水平变化。结果本组MHD患者血脂异常以TG升高和HDL-C降低为主要特点,使用辛伐他汀治疗8周后,试验组血清TC、TG显著降低,LDL-C下降,HDL-C轻度升高,TG降低幅度高于TC、LDL-C下降幅度。结论本研究显示,每晚口服辛伐他汀20mg 8周能显著降低MHD患者TC、TG水平,TG对辛伐他汀治疗更加敏感,TG降低的幅度或比例超过TC和LDL-C下降的幅度或比例。 Objective To observe the serum lipid profile and its characteristic in a group of maintenance hemodialysis (MDH) patients.And prospectively study the influence of simvastatin on total cholesterol(TC),triglyceride(TG), low-density lipoprotein cholesterol(LDL-C),and high-density lipoprotein cholesterol(HDL-C) of MDH patients.Methods The serum lipid levels of 29 MHD patients were assayed.And those with dyslipidemia were assigned into experiment group(13 cases) and applied with 20mg simvastatin per night for 8 weeks.Others(16 cases) were assigned into control group.Before and after experiment, the serum TC,TG,LDL-C and HDL-C levels were determined.Results The main features of dyslipidemia in the group of MHD patients were elevation of TG and decrease of HDL-C concentration.After 8-week simvastatin intervention, the TC and TG levels in experiment group were significantly lowered,LDL-C decreased and HDL-C rose by a certain margin,though not significantly.The percentage change of TG was remarkably higher than that of TC or LDL-C. Conclusion According to our preliminary study,20mg simvastatin for 8 weeks could significantly lower TC and TG in a group of MHD patients.And serum TG seemed more sensitive to simvastatin treatment and its alteration margin or proportion were larger than that of TG or LDL-C.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2009年第S1期46-49,共4页 Chinese Journal of Practical Internal Medicine
关键词 辛伐他汀 血液透析 总胆固醇 三酰甘油 低密度脂蛋白 高密度脂蛋白 simvastatin hemodialysis total cholesterol(TC) triglyceride(TG) low-density lipoprotein cholesterol high-density lipoprotein cholesterol
  • 相关文献

参考文献14

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5222
  • 2王刚,郑尘非,刘毅,许菲菲,徐玉兰.舒降之对维持血透患者微炎症状态的影响[J].中国中西医结合肾病杂志,2004,5(9):515-518. 被引量:10
  • 3Avram MM,Fein PA,Antignani A,et al.Cholesterol and lipid disturbances in renal disease:the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis. The American Journal of Medicine . 1989
  • 4Baigent C,Landray M,Leaper C,et al.First United Kingdom Heart and Renal Protection (UK-HARP-I) study:biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. American Journal of Kidney Diseases . 2005
  • 5Chang JW,Yang WS,Min WK,et al.Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. American Journal of Kidney Diseases . 2002
  • 6Shurraw S,Tonelli M.Statins for treatment of dyslipidemia in chronic kidney disease. Peritoneal Dialysis International . 2006
  • 7Allan Sniderman Katherine Cianflone Peter O. Kwiterovich,Jr. Tom Hutchinson Paul Barre and Sarah Prichard.Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis. Atherosclerosis . 1987
  • 8Muntner P,Hamm LL,Kusek JW,et al.The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Annals of Internal Medicine . 2004
  • 9Avran MM,Goldwasser P,Burrell DE,et al.The uremic dyslipi-demia: A cross-sectional and longitudinal study. American Journal of Kidney Diseases . 1992
  • 10Jones PH,Davidson MH,Stein EA,et al.Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). The American Journal of Cardiology . 2003

二级参考文献166

共引文献5230

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部